Thrombosis prophylaxis for factor V.sup.LEIDEN carriers
First Claim
Patent Images
1. A method of reducing the risk of thrombosis in a person who carries a Factor VLEIDEN allele, the method comprising the step of:
- administering to the person an amount of Tissue Factor Pathway Inhibitor (TFPI) or active fragment thereof sufficient to achieve plasma levels of TFPI which are higher than 89 ng/ml.
2 Assignments
0 Petitions
Accused Products
Abstract
Persons having the Factor VLEIDEN mutation and a lower than average plasma level of TFPI have been found to be at elevated risk of thrombosis. Prophylactic methods for reducing the risk of thrombosis employ the administration of TFPI to achieve higher levels in the plasma.
4 Citations
14 Claims
-
1. A method of reducing the risk of thrombosis in a person who carries a Factor VLEIDEN allele, the method comprising the step of:
administering to the person an amount of Tissue Factor Pathway Inhibitor (TFPI) or active fragment thereof sufficient to achieve plasma levels of TFPI which are higher than 89 ng/ml. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
Specification